CD2 expressed on the surface of NLCs, binds the lymphocyte function-associated antigen 3 (LFA-3) or CD 58, expressed on CLL cells, inhibiting their programmed death. This evidence concerns the gene CD58 and B-cell chronic lymphocytic leukemia.